Apps

openserveblockversewordysbillionaire.aiyourlistWhiteboardAppquizieunschool

News

Home
Politics
World
Sports
Markets
Business
Entertainment
Music
Health
Tech
Science
Good News

Want your own hosted, self-optimizing clone of this — or any OpenServe site? Open Development for enterprise →

© OpenServe Holdings LLC

Privacy Notice Data rights Terms of Service Feedback Cookie NoticeHelp Acceptable Use Copyright AI Notice Your Privacy Choices Subprocessors Data Processing Addendum Installed App Terms Company Solutions Free assessment Investors Get the app Contact

IJR News — today's news from every side

📊 Approval moversDonald Trump100%

Novo says Wegovy trial moved 40% of young children out of obesity — 7hIn Novo Nordisk's STEP Young phase 3 trial, once-weekly semaglutide plus lifestyle changes reduced BMI and 40.4% of children aged 6-11 with obesity no longer met obesity criteria after 68 weeks, versus 0% on placebo. Safety remained consistent with prior semaglutide studies, adding to the growing body of pediatric obesity treatment data.

Chris Dalton Glad there's finally something beyond diet and exercise lectures for kids who genuinely struggle, this could change a lot of families' lives.

China obesity rate expected above 65% by 2030 — Aug 24, 2026China’s National Health Commission suggests obesity could exceed 65% of the population by 2030, triggering a push by major drugmakers to promote GLP-1 weight-loss injections through indirect public advertising in places like metro stations and stadiums due to bans on direct prescription-drug ads. Companies including Novo Nordisk, Lilly, Pfizer, and Innovent Biologics are vying for market share, with Lilly leading online sales on Alibaba/JD.com and campaigns emphasizing obesity risks and related conditions such as sleep apnea without naming products.

Novo Nordisk launches Wegovy pill in Germany as Eli Lilly readies rival — 6dNovo Nordisk is rolling out Wegovy as an oral weight‑loss pill in Germany, the EU’s first market to receive the formulation after EU approval, with prices expected around €170–€280 and strong competition from Eli Lilly’s Foundayo on the horizon. The launch leverages Wegovy’s dominant position in the oral obesity market, while analysts weigh the impact of the tablet on growth, pricing, and payer access across Europe.

Tom Gallagher Curious how many insurers in Germany will actually cover this at launch, oral obesity meds still feel like they're priced for a niche market.

Video — YouTubeMISTRIAL: MA v. Lindsay Clancy - Day 28 | Accused Killer Mom TrialCOURT TV · 3.4M views · Sep 4, 2026

Lilly Plans $2.88B Merida Autoimmune AcquisitionBusiness — 4dEli Lilly is rapidly expanding beyond its obesity-and-diabetes blockbuster lineup, striking two multi-deal paths: a $2.875 billion-plus acquisition of Merida Biosciences to broaden its autoimmune and antibody-directed therapies, and a $3.83 billion spree to acquire three biotech firms—Curevo, LimmaTech Biologics, and Vaccine Company—to build a broader vaccine and infectious-disease pipeline. The moves underscore a strategy to diversify growth into immunology, infectious diseases, and autoantibody therapies while managing revenue risk from reliance on a small number of weight‑loss drugs.

IJRDemocrats Go Quiet On Climate After Biden-Era Regulatory BlitzParis Apodaca · 6 min · 1h

Hanmi Genentech obesity drug deal worth $2.3B reported — Aug 24, 2026Hanmi Pharmaceutical has signed an exclusive, worldwide license with Genentech for HM17321, a long-acting UCN2 analog aimed at obesity that promises weight loss with muscle preservation, with Genentech taking over development from Phase 2 onward outside Korea. The deal could reach about $2.3 billion, including a $190 million upfront, up to $2.1 billion in milestones, and future royalties, subject to U.S. antitrust clearance and successful clinical progression.

RankingMost underrated cities in AmericaAmerica's biggest cities hog all the spotlight, while dozens of smaller gems get overlooked despite great food, culture, and character. These underrated cities deserve recognition beyond the usual coastal favorites. Cast your vote and help crown the most underappreciated city in the country.693 votes · 21 candidates

Lilly's $2.9B deal adds treatments for Graves' disease and food allergies — Aug 31, 2026Eli Lilly is acquiring Merida Biosciences for about $2.88 billion in cash, expanding its immunology and allergic-disease pipeline beyond its obesity drugs, with the deal expected to close in Q4 2026 and marking Lilly’s ongoing aggressive M&A strategy. Merida’s lead program MER511 targets Graves’ disease and thyroid eye disease, while MER769 is in preclinical development for food allergy, asthma and chronic spontaneous urticaria, underscoring a broadened portfolio as Lilly references roughly $29 billion in upfront and milestone payments this year across acquisitions.

Jillian Michaels Faces Off With 4 Body Positivity Activists Who Object To Her Obesity Claim — Mar 16, 2026Fitness expert Jillian Michaels debated four body positivity activists who disagreed with her about obesity during a Monday episode of Jubilee’s “Surrounded” series. Michaels claimed on the Jubilee episode that “Obesity…

Keto Diet Outperforms Other Diets in U.S. TrialHealth — Aug 27, 2026A ketogenic, low-carbohydrate, high-fat diet may offer greater metabolic benefits for people with obesity and prediabetes, including reductions in liver fat and improvements in blood sugar control, compared with Mediterranean or low-fat diets, according to multiple randomized trials. While all three diets aid weight loss, the keto plan showed the strongest signals for metabolic health beyond weight loss itself.

Pelosi Addresses Her ‘Morbidly Obese’ Comments About Trump: ‘I Didn’t Know He’d Be so Sensitive’Reporting — May 19, 2020House Speaker Nancy Pelosi (D-Calif.) is responding to President Donald Trump’s attack on her after she called him “morbidly obese.” “I didn’t know that he would be so sensitive,” Pelosi said during an interview on…

On X · @MLBMLB Highlights Spectacular Defensive Catch by Brewers' Luis Lara in Win Over CubsHighlight-reel defensive play by young Brewers outfielder Luis Lara praised widely for athleticism and clutch impact in rivalry win; reactions mostly positive with limited Cubs-fan trolling or dismissal but no deep split.1,117 likes · 24m

‘Dangerous and Reckless’: GOP Rep Kicked Out of Congress Slams ‘Glorifying Obesity’Reporting — Jan 16, 2024Former Rep. George Santos (R-N.Y.) shared his journey using the weight loss drug Ozempic and slammed the “glorifying” of obesity as being “dangerous and reckless.” In a post on X, formerly Twitter, Santos shared he…

Video — YouTubeMystery Ghost Ball in Wrigley's Ivy...🤔💀Dugout Daze · 24.4M views · Aug 30, 2026

Unfit to Serve? Obesity Epidemic Creating Recruitment Woes, National Security Risk – Biden’s DEI Policies Don’t HelpOpinion — Sep 3, 2023The U.S. military has faced a number of problems recently in recruiting new soldiers, especially in a nation with an increasing obesity problem among its young people. But President Joe Biden’s obsession with pushing…

VS BattleJim Carrey vs Adam SandlerRubber-faced mania versus deadpan slob comedy — two 90s comedy titans, two entirely different engines.Jim Carrey vs Adam Sandler · 146 votes — pick a side

Oval Office Scare: Guest Collapses During Trump Obesity-Drug Event, Rushed by Dr. Oz — Nov 7, 2025A White House press event took a frightening turn Thursday afternoon when a guest collapsed in the Oval Office during an obesity-drug announcement. According to the New York Post , President Donald Trump and Dr. Mehmet…

Paris opens first butter boutique with 30 varieties — Aug 26, 2026Paris has opened Le Butter Shop, the city’s first boutique dedicated entirely to butter, offering 30 varieties from small producers and allowing customers to sample by the spoon before purchasing in sizes from 10 grams to a kilogram near the Eiffel Tower. The shop spotlights France’s butter culture, with flavors ranging from classic to sweet and savory, a wine-like tasting approach from owner Erwan Leo, and plans for future flavors, amid a backdrop of high per-person butter consumption and a relatively low obesity rate.

England's young women face Type 2 diabetes surgeHealth — Jul 21, 2026A Lancet study and Imperial College London analysis show a sharp rise in early-onset type 2 diabetes in England, especially among women under 40 and those aged 20-29, linked to rising obesity. While diagnoses in older adults decline, experts warn the trend carries greater health risks and call for earlier, more intensive obesity and lifestyle interventions.

Daily Caller News FoundationDemocrats Go Quiet On Climate After Biden-Era Regulatory BlitzDemocrats are increasingly dropping climate change from their midterm messaging after spending the Biden years pursuing an aggressive environmental agenda. 1h

India Abandons Front-Label Warnings on Chips, Soda — Aug 25, 2026A cross-border look at India’s fight over front-of-pack nutritional warnings shows big food firms continuing to resist prominent front labels, with regulators proposing a black-and-white table of sugar, fat and salt instead of colorful warnings and the Supreme Court now reviewing the decision amid concerns that up to 450 million Indians could be obese or overweight by 2050. Experts argue that interpretive labeling can promote healthier choices, but industry groups and regulators remain at odds over how to balance clarity, cultural cuisine differences, and portion control.

QuizThe Four-Letter Type TestThe classic sixteen-types test — twenty questions, four axes, your letters computed for real, and an AI portrait written for your exact mix.4 min · today's quiz

Medicare GLP-1 Bridge Program Expands Youth Obesity UseHealth — Jul 19, 2026GLP-1 therapies are expanding from metabolic control into broader markets and transformative obesity treatment in the U.S. and India, with low-cost generics changing demand and public perception. Ongoing research explores multispecific GLP-1–based approaches, regenerative implications of GLP-1 signaling, and the optimal timing of GLP-1 therapy around bariatric surgery, suggesting after-MBS initiation may yield the strongest survival and complication benefits.

GLP-1 obesity drugs linked to fewer alcohol hospitalizationsHealth — Jul 21, 2026A multi-trial analysis of about 40,700 adults found GLP-1 receptor agonists such as semaglutide and tirzepatide are associated with substantially lower alcohol-related hospital admissions across diabetics, obesity, and alcohol-use disorder groups, with reductions ranging from roughly 26% to 65% depending on the comparison. Experts say the findings hint at a potential role for these weight‑loss and diabetes drugs in treating alcohol-use disorders, though more research is needed to confirm causality and guide use.

Video — YouTubeEVAN (에반) 'Death of Me' Official MVHYBE LABELS · 1.5M views · Sep 7, 2026

Novo Nordisk Tests Lower Wegovy Doses — Aug 19, 2026Novo Nordisk is conducting a late-stage study to identify the lowest effective dose of Wegovy, testing two low doses against placebo in 450 participants as it seeks to preserve its share in a obesity drug market projected to exceed $100 billion annually by 2030. The trial, which began on August 12 and runs through 2028, follows competitive pressure from Eli Lilly and comes after Wegovy's recent sales performance, with dose strengths undisclosed.

HUNG CAO: Make The Military Care About Being Lethal AgainOpinion — Dec 18, 2024It is estimated that fewer than 23% of Americans between 17 and 24 are qualified to serve in the U.S. military. The reasons range from obesity and drug use to mental health issues. Today, only a small percentage of our…

IJRTrump Admin Splinters Over AI’s Right To Train On Americans’ Copyrighted WorkDylan Kresak · 4 min · 4h

Sprinting Triggers Widespread Blood Protein ShiftsHealth — Aug 21, 2026Short bursts of sprint-interval exercise provoke widespread molecular changes in the bloodstream, altering hundreds of proteins and metabolites immediately and linking these shifts to lower risks of type 2 diabetes, obesity, and cardiovascular disease, with sprinting outperforming steady-state moderate cardio. In addition, research highlights a muscle-released molecule, BAIBA, that boosts muscle function and may offer therapeutic potential, while other findings point to rapid protein and metabolite remodeling driven by intense exercise and slower, more modest changes from moderate activity.

EMILY STACK: Trump Administration Delivers On Promise To Make America’s Kids Healthy Again — Oct 1, 2025For years, American mothers have navigated the complex maze of feeding their children meals they want to eat, while also worrying about obesity, chronic illness, and the many unhealthy offerings crowding every grocery…

Pelosi Insists Trump Should Not Be Taking Hydroxychloroquine, Calls Him ‘Morbidly Obese’Reporting — May 19, 2020House Speaker Nancy Pelosi (D-Calif) is weighing in with deep concern about President Donald Trump’s health following his decision to take an unproven drug to treat the coronavirus, hydroxychloroquine. Pelosi appeared…

Frequent Food Delivery App Users Linked To Higher Obesity Rates ‌Reporting — Aug 21, 2024A person taking out food out of the bag. Research found that low income people were twice as likely to vote through the food delivery apps than high income people. (MIKHAILL NILOV/PEXELS) “> Online food delivery app…

Southwest Airlines’ Unique Plus-Size Passenger Policy Is Causing ControversyOpinion — Dec 13, 2023Call it a free-market fight in flight. A Southwest Airlines policy that allows obese customers to occupy an extra seat, or even two, free of charge is being “celebrated” by overweight passengers, according to a…

On X · @AdamSchefterNew York Giants Release Veteran WR Darius SlaytonAdam Schefter’s post announces the Giants have released longtime wide receiver Darius Slayton. The news is trending due to Schefter’s prominence, timing near the season start, and Slayton’s status as the team’s longest-tenured player. Reactions include stats, memes, landing-spot speculation, and debate over whether the move was overdue.1,256 likes · 24m

Video — YouTubeMISTRIAL: Lindsay Clancy Murder Trial — MA v. Lindsay Clancy — Day 28Law&Crime Trials · 1.9M views · Sep 4, 2026